Early growth

Proveca is a specialist pharmaceutical company focused on medicines for children. It's lead product, Sialanar™ is a licensed drug (PUMA) for chronic pathological drooling based on a new formulation of a well-known medicine and is available first in the UK followed by the rest of Europe.

Proveca has a very strong management team. The two founders have extensive experience in the development and licensing of medicines for children - having secured two of the current three Paediatric Use Market Authorisations (PUMAs) approved to date.  In addition, the commercial team have proven success in pharmaceutical sales and marketing at c-level with global pharma.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Nick Wright


view complete team

Contact us

Tel: 01625 344300